32176-94-6

Basic information

• Product Name: Benzoic acid, 2,5-dimethoxy-4-methyl-
• CAS NO: 32176-94-6
• Molecular Formula: C10H12O4
• Molecular Weight: 196.203
• Mol File: 32176-94-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2,5-dimethoxy-4-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2,5-dimethoxy-4-methyl-(32176-94-6)
• EPA Substance Registry System: Benzoic acid, 2,5-dimethoxy-4-methyl-(32176-94-6)

Safety Data

• Hazardous Substances Data: 32176-94-6(Hazardous Substances Data)

Upstream product

• 32176-96-8 2,5-dimethoxy-4-methylphenylmethanol 
• 24599-58-4 2,5-dimethoxy toluene 
• 50-85-1 2-hydroxy-p-toluic acid 
• 939019-26-8 2,5-dihydroxy-4-methyl-benzyl alcohol 
• 95-71-6 2-methylbenzene-1,4-diol 
• 4925-88-6 2,5-dimethoxy-4-methylbenzaldehyde 
• 3209-15-2 4-methyl-2,5-dihydroxybenzoic acid 
• 77-78-1 dimethyl sulfate 
• 75056-76-7 1-iodo-2,5-dimethoxy-4-methylbenzene 
• 51267-09-5 2,5-dimethoxy-4-methyl-benzonitrile 

Downstream Products

• 82485-85-6 2,5-dimethoxy-4-methylbenzoic acid methyl ester 
• 34238-59-0 2,5-dimethoxy-4-methylaniline 
• 53939-66-5 acetic acid-(2,5-dimethoxy-4-methyl-anilide) 
• 89368-17-2 2-(2,5-dimethoxy-4-methylphenyl)-4,4-dimethyl-4,5-dihydro-oxazole 
• 32185-64-1 1,4-dimethoxy-2-methyl-5-nitrobenzene 
• 53197-61-8 N-2,5-Dimethoxybenzoylglycin 
• 65849-94-7 2,5-Dimethoxy-4-methyl-benzoyl chloride 
• 80893-71-6 2,5-dimethoxy-1-(3'-methoxy-2'-methoxycarbonylphenyl)methyl-4-methylcyclohexa-2,5-diene-1-carboxylic acid 
• 21004-11-5 2,5-dimethoxyterephthalic acid 

Relevant articles and documents

Seven-membered ring compound and application thereof in prevention and treatment of diabetes and metabolic syndrome

The invention discloses a seven-membered ring compound and application thereof in prevention and treatment of diabetes and metabolic syndrome. The structure of the seven-membered ring compound is as shown in a general formula I, and definitions of substituent groups are as shown in the specification and claims. The seven-membered ring compound of the invention has an extremely excellent effect ofpreventing or treating diabetes and metabolic syndrome.

Triazole derivatives and pharmaceutical compositions comprising them

The present invention relates to compounds of formula (I) and their pharmaccutically acceptable salts, solvates, hydrates and polymorphs. These compounds are powerful and selective CCK1 receptor agonists.